IRIS
SANTINI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 21.132
NA - Nord America 5.976
EU - Europa 2.044
SA - Sud America 1.579
AF - Africa 152
OC - Oceania 71
AN - Antartide 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 30.958
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.328
US - Stati Uniti d'America 5.657
CN - Cina 2.843
HK - Hong Kong 2.689
BR - Brasile 1.196
GB - Regno Unito 770
VN - Vietnam 684
IT - Italia 391
DE - Germania 241
AR - Argentina 178
IN - India 173
CA - Canada 167
MX - Messico 106
ID - Indonesia 93
NL - Olanda 87
ZA - Sudafrica 79
FI - Finlandia 75
AU - Australia 65
UA - Ucraina 64
JP - Giappone 61
EC - Ecuador 59
PL - Polonia 59
TR - Turchia 45
ES - Italia 43
FR - Francia 40
RU - Federazione Russa 40
PY - Paraguay 39
BD - Bangladesh 33
CZ - Repubblica Ceca 33
SE - Svezia 33
CO - Colombia 32
CL - Cile 26
PE - Perù 24
CH - Svizzera 18
LT - Lituania 18
BE - Belgio 17
EE - Estonia 17
KR - Corea 15
MA - Marocco 15
EG - Egitto 14
UZ - Uzbekistan 14
SA - Arabia Saudita 13
VE - Venezuela 13
IQ - Iraq 12
AZ - Azerbaigian 10
IL - Israele 10
AT - Austria 9
DO - Repubblica Dominicana 9
PK - Pakistan 9
TW - Taiwan 9
UY - Uruguay 9
PH - Filippine 8
SI - Slovenia 8
KZ - Kazakistan 7
PT - Portogallo 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
GT - Guatemala 5
JO - Giordania 5
MD - Moldavia 5
MY - Malesia 5
TH - Thailandia 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
CY - Cipro 4
DM - Dominica 4
DZ - Algeria 4
HN - Honduras 4
IE - Irlanda 4
KH - Cambogia 4
LU - Lussemburgo 4
NP - Nepal 4
RS - Serbia 4
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
HR - Croazia 3
IR - Iran 3
JM - Giamaica 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AQ - Antartide 2
BF - Burkina Faso 2
BO - Bolivia 2
BZ - Belize 2
Totale 30.896
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.671
Singapore 1.961
Ashburn 1.646
Hefei 1.389
Boardman 799
London 672
San Jose 521
Shanghai 478
Dallas 445
Beijing 437
Ho Chi Minh City 237
Los Angeles 174
San Francisco 164
Hanoi 151
Council Bluffs 147
São Paulo 122
Pune 103
Seattle 102
Toronto 96
Munich 95
Santa Clara 85
Rome 79
New York 74
Washington 66
Warsaw 52
Mexico City 50
Tokyo 49
Rio de Janeiro 45
Amsterdam 44
Turku 40
Brooklyn 39
Johannesburg 37
Montreal 36
Helsinki 35
Melbourne 33
Chicago 32
Haiphong 32
Brno 29
Thái Bình 28
Boston 27
Stockholm 27
Biên Hòa 26
Da Nang 26
Chennai 24
Milan 23
Belo Horizonte 22
Buenos Aires 21
Naples 20
Guayaquil 19
Quito 19
Secaucus 19
Brasília 18
Asunción 17
Lima 17
Phoenix 17
Canberra 16
Ninh Bình 16
Sydney 16
West Jordan 16
Ribeirão Preto 15
Atlanta 14
Campinas 14
Charlotte 14
Tashkent 14
Ankara 13
Manchester 13
Paris 13
Curitiba 12
Hanover 12
Hasselt 12
Jakarta 12
Porto Alegre 12
St Louis 12
Oklahoma City 11
Salvador 11
Sorocaba 11
Bắc Giang 10
Caxias do Sul 10
Guangzhou 10
Ha Long 10
Haikou 10
Hải Dương 10
Riyadh 10
Viamão 10
Bogotá 9
Boydton 9
Bắc Ninh 9
Denver 9
Goiânia 9
Guarulhos 9
Joinville 9
New Delhi 9
Santo André 9
The Dalles 9
Cairo 8
Camaçari 8
Fortaleza 8
Hortolândia 8
Hyderabad 8
Maceió 8
Totale 14.134
Salva come PNG Salva come JPEG
Nome #
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 239
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 235
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 233
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 224
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 219
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 218
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 215
Designing a broad-spectrum integrative approach for cancer prevention and treatment 214
Early impairment of food intake in patients newly diagnosed with cancer 211
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 211
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 210
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 208
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 206
A key opinion leader interview with Prof D Santini: insight into cancer research. 205
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 205
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 201
Premetastatic niche: ready for new therapeutic interventions? 200
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer 200
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 200
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 200
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 200
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 199
COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification 199
In Situ Identification of CD44+/CD24− cancer cells in primary human breast carcinomas 198
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 198
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 195
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 194
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 191
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 191
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 191
Prevention of radiotherapy-induced emesis 191
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 190
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 186
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 184
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 183
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 182
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 180
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 177
Docetaxel induced pericardial effusion 174
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 162
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 151
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 133
A giant sarcoma of the parotid gland: A case report and review of the literature 127
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 121
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 121
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 119
Anestesia e malattie non comuni 117
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 116
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 114
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 113
'Old' and 'new' drugs for the treatment of cancer pain 112
Colorectal carcinomas and PTEN/MMAC1 gene mutations 111
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 109
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome 107
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 106
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 105
Biological effects of cabozantinib on bone microenvironment 105
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 104
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 103
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer 103
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 103
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 103
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 102
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 102
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 102
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 100
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 100
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 100
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 99
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 99
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 99
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 99
Idiosyncratic reaction after oxaliplatin infusion 98
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 98
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 98
[Treatment of stage-I seminoma. Critical review] 97
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 97
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 97
Atypical chronic head and neck pain: don't forget Eagle's syndrome 96
Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature 95
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 95
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 95
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 94
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 93
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 93
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 93
A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC) 92
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 87
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 87
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 86
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 86
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 84
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 83
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 80
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients 74
Classic Kaposi Sarcoma: to treat or not to treat? 73
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 72
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 71
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis 71
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients 65
Totale 13.974
Salva come PNG Salva come JPEG
Categoria #
all - tutte 305.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 305.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.008 0 4 5 8 73 10 15 4 42 20 23 804
2022/2023203 18 7 3 13 16 7 18 20 9 3 80 9
2023/20242.295 52 281 95 171 237 1.039 17 154 23 59 75 92
2024/202518.553 334 274 922 147 171 510 314 63 1.954 1.573 5.751 6.540
2025/20269.034 1.870 776 1.374 2.466 701 1.230 617 0 0 0 0 0
Totale 31.093